State-of-the-Art Strategies for Addressing Selection Bias When Comparing Two or More Treatment Groups

by Beth Ann Griffin, Daniel F. McCaffrey, Lane F. Burgette, Matthew Cefalu, Brian G. Vegetabile, Joseph D. Pane, Donna L. Coffman

Download Support Files

Video Slides

FormatFile SizeNotes
zip file 7.2 MB

The file(s) provided above are ZIP-formatted archives, which most modern systems can natively unpack. If your computer does not unpack the archive when you double-click it, you may need to use a separate decompression program such as UnZip.

The estimation of causal effects is one of the primary activities of most longitudinal research studies. Controlled experiments are held as the gold standard for estimating such effects. However, experiments are often infeasible and only observational data, in which participation in a program or intervention is out of the control of the researchers, are available for analysis. RAND statisticians and their colleagues have developed tools to implement new causal effect estimation methods that use observational data.

This course introduces causal modeling using the potential outcomes framework and propensity score weights to estimate causal effects from observational data. Presenters demonstrate how propensity score weights can be utilized to estimate intervention effects and how to evaluate balance before and after propensity score weighting and how to fit models with available software in Stata. Tools are also available in SAS, R, and Shiny. Those who take the course learn how to implement propensity score weighting using state-of-the-art methods and gain insights into some of the practical issues around evaluating the quality of propensity score weights for two or more treatment groups and time-varying treatments.

The recordings are from a full-day course presented at Cardiff University, and the content has not undergone formal quality assurance review. Funding for the course was generously supported by grants 1R01DA034065 and 1R01DA045049 from the National Institute of Drug Abuse.

Research conducted by

This report is part of the RAND Corporation Conference proceeding series. RAND conference proceedings present a collection of papers delivered at a conference or a summary of the conference.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.